Prognosis and outcome of relapsed acute lymphoblastic leukemia: A Hong Kong pediatric hematology and Oncology Study Group report

about

Prognosis and outcome of relapsed acute lymphoblastic leukemia: A Hong Kong pediatric hematology and Oncology Study Group report

Item

http://www.wikidata.org/entity/Q59103913

description

im Mai 2012 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 18 May 2012

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в травні 2012

@uk

name

Prognosis and outcome of relap ...... nd Oncology Study Group report

@en

Prognosis and outcome of relap ...... nd Oncology Study Group report

@nl

type

Item

label

Prognosis and outcome of relap ...... nd Oncology Study Group report

@en

Prognosis and outcome of relap ...... nd Oncology Study Group report

@nl

prefLabel

Prognosis and outcome of relap ...... nd Oncology Study Group report

@en

Prognosis and outcome of relap ...... nd Oncology Study Group report

@nl

P1476

Prognosis and outcome of relap ...... nd Oncology Study Group report

@en

P2093

Alex Wing Kwan Leung

http://www.w3.org/2001/XMLSchema#string

Chi Kong Li

http://www.w3.org/2001/XMLSchema#string

Chung Wing Luk

http://www.w3.org/2001/XMLSchema#string

Frankie Wai Tsoi Cheng

http://www.w3.org/2001/XMLSchema#string

Lee Vincent

http://www.w3.org/2001/XMLSchema#string

Siu Cheung Ling

http://www.w3.org/2001/XMLSchema#string

P2860

Outcome of patients treated for relapsed or refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium study.

Long-term results of St Jude Total Therapy Studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemia.

Long-term follow-up of the United Kingdom medical research council protocols for childhood acute lymphoblastic leukaemia, 1980-2001

Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children's Oncology Group study.

Long-term results of the children's cancer group studies for childhood acute lymphoblastic leukemia 1983-2002: a Children's Oncology Group Report.

Minimal residual disease prior to stem cell transplant for childhood acute lymphoblastic leukaemia.

Minimal residual disease (MRD) status prior to allogeneic stem cell transplantation is a powerful predictor for post-transplant outcome in children with ALL.

Long-term outcome of initially homogenously treated and relapsed childhood acute lymphoblastic leukaemia in Austria--a population-based report of the Austrian Berlin-Frankfurt-Münster (BFM) Study Group.

Cooperative study group for childhood acute lymphoblastic leukaemia (COALL): long-term results of trials 82,85,89,92 and 97.

Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy: results of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Münster Group 87.

P304

454-460

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PBC.24162

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Alan KS Chiang

Anselm Chi-Wai Lee

Daniel Ka-leung Cheuk

P577

2012-05-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22610685

http://www.w3.org/2001/XMLSchema#string

P921

leukemia